signaling gateway home
registrationelectronic alerthelpcontact ussite guidesearch
cell signaling update signaling update home updates  news  research library featured articles conferences

T-Cell Signalling: The way of CARMA

home | subscribe

Together, two new papers advance our understanding of T-cell receptor signaling. They indicate that CARMA1 has an essential and specific role in TCR-mediated NF-kappaB activation, recruiting BCL10 to the TCR in rafts and allowing the activation of BCL10 by PKC.

This month, our understanding of T-cell receptor (TCR) signalling has been advanced by two studies in Nature Immunology that show that the scaffolding protein CARMA1 links the TCR to nuclear factor-kappaB (NF-kappaB) activation.

After the recognition of antigen by the TCR, many signalling pathways are triggered simultaneously, which leads to the activation of transcription factors, such as NF-kappaB, NFAT and AP1. NF-kappaB activation is essential for full T-cell activation, but the upstream signalling pathway is poorly defined. BCL10 — a caspase-recruitment domain (CARD)-containing protein — is known to have a role in TCR-dependent NF-kappaB activation, as is the novel protein kinase C PKCthetas, but it is not clear how these components are linked to the TCR. Known binding partners of BCL10 include the CARD-containing subfamily of membrane-associated guanylate kinase (MAGUK) proteins, the CARMA scaffolding proteins.

Gaide et al. looked at the localization of CARMA1 — the only family member that is expressed in lymphocytes — in the Jurkat human T-cell line by immunoprecipitation and confocal microscopy using a polyclonal antibody. They show that CARMA1 is recruited to the TCR after stimulation with anti-CD3 antibody, together with its binding partner BCL10.

How important is the recruitment of CARMA1–BCL10 to the TCR for T-cell activation? Gaide et al. investigated this by generating a mutant CARMA1 protein that cannot bind to BCL10 and that functions as a dominant-negative inhibitor of CARMA1 activity. When Jurkat cells were transfected with the dominant-negative CARMA1 and stimulated with anti-CD3 antibody, NF-kappaB activation was inhibited markedly and interleukin-2 (IL-2) secretion was completely blocked; however, other TCR signalling pathways, such as the activation of ERK, JNK and PLCgamma, and Ca2+ mobilization, were not affected.

Wang et al. isolated a mutant Jurkat clone in which anti-CD3/anti-CD28 antibody-triggered JNK and ERK signalling was preserved, but NF-kappaB activation was disrupted. This defect was shown to be downstream of PKCthetas and upstream of IKK (inhibitor of NF-kappaB kinase) and to prevent IL-2 expression. The mutant cells are defective in CARMA1 expression, and reconstitution with CARMA1 rescued the defect in both NF-kappaB activation and IL-2 expression. This result provides genetic evidence that CARMA1 is an essential signalling component in the TCR signalling pathway. The authors also show that CARMA1 is essential for optimal recruitment of BCL10 to the membrane and that it enhances the phosphorylation of BCL10 by PKCthetas.

It has been proposed that early T-cell signalling events are initiated in membrane lipid microdomains known as rafts; so, are CARMA1 and BCL10 recruited to the rafts? Using confocal microscopy, Gaide et al. show that CARMA1 is enriched in rafts after cross-linking of rafts. A biochemical analysis of anti-CD3-stimulated Jurkat T cells, using detergents to isolate rafts, showed that CARMA1 is present constitutively in the raft fraction and that its concentration is increased after TCR stimulation. BCL10, which is excluded from rafts in resting cells, also translocates to rafts after stimulation. It is not clear how CARMA1 is targeted to rafts, but the authors' preliminary results indicate that CARMA1 might bind to a raft protein component, possibly through one of its protein–protein interaction domains.

Together, these papers indicate that CARMA1 has an essential and specific role in TCR-mediated NF-kappaB activation; it recruits BCL10 to the TCR in rafts and allows the activation of BCL10 — either directly or indirectly — by PKCthetas.


Jennifer Bell

References

  1. Gaide, O. et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappaB activation. Nature Immunol. August 5 2002 (DOI 10.1038/ni830)Article |
  2. Wang, D. et al. A requirement for CARMA1 in TCR-induced NF-kappaB activation. Nature Immunol. August 5 2002 (DOI 10.1038/ni824)Article |

Links

WEB SITES
Xin Lin's lab
Margot Thome's lab

more more stories

 Nature Publishing Group

HOME | SIGNALING UPDATE | MOLECULE PAGES | DATA CENTER | ABOUT US
registration | e-alert | help | contact us | site guide | search

© 2002-2008 Nature Publishing Group

Privacy Policy